Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
European Journal of Pharmacology
|
April 3, 2012
Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase
Orit Bar-Am, Aviva Gross, Rachel Friedman, et al.
Progress in Neurobiology
|
July 31, 2007
Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents
Silvia Mandel, Tamar Amit, Orit Bar-Am, et al.
Journal of Molecular Neuroscience : MN
|
August 30, 2008
The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats
Orit Bar-Am, Orly Weinreb, Tamar Amit, et al.
Progress in Neurobiology
|
July 6, 2010
Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity
Orly Weinreb, Tamar Amit, Orit Bar-Am, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 9, 2005
Regulation of Bcl-2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine
Orit Bar-Am, Orly Weinreb, Tamar Amit, et al.
Journal of Neurochemistry
|
December 17, 2009
The neuroprotective mechanism of 1-(R)-aminoindan, the major metabolite of the anti-parkinsonian drug rasagiline
Orit Bar-Am, Orly Weinreb, Tamar Amit, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 4, 2003
The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing
Merav Yogev-Falach, Tamar Amit, Orit Bar-Am, et al.
Antioxidants & Redox Signaling
|
October 6, 2010
Does 1-(R)-aminoindan possess neuroprotective properties against experimental Parkinson's disease?
Orly Weinreb, Orit Bar-Am, Ksenia Prosolovich, et al.
Molecular Neurobiology
|
August 1, 2012
Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in mice
Lana Kupershmidt, Tamar Amit, Orit Bar-Am, et al.
Journal of Neurochemistry
|
August 8, 2007
The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases
Lana Kupershmidt, Tamar Amit, Orit Bar-Am, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
European Journal of Pharmacology
|
April 3, 2012
Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase
Orit Bar-Am, Aviva Gross, Rachel Friedman, et al.
Progress in Neurobiology
|
July 31, 2007
Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents
Silvia Mandel, Tamar Amit, Orit Bar-Am, et al.
Journal of Molecular Neuroscience : MN
|
August 30, 2008
The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats
Orit Bar-Am, Orly Weinreb, Tamar Amit, et al.
Progress in Neurobiology
|
July 6, 2010
Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity
Orly Weinreb, Tamar Amit, Orit Bar-Am, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 9, 2005
Regulation of Bcl-2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine
Orit Bar-Am, Orly Weinreb, Tamar Amit, et al.
Journal of Neurochemistry
|
December 17, 2009
The neuroprotective mechanism of 1-(R)-aminoindan, the major metabolite of the anti-parkinsonian drug rasagiline
Orit Bar-Am, Orly Weinreb, Tamar Amit, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 4, 2003
The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing
Merav Yogev-Falach, Tamar Amit, Orit Bar-Am, et al.
Antioxidants & Redox Signaling
|
October 6, 2010
Does 1-(R)-aminoindan possess neuroprotective properties against experimental Parkinson's disease?
Orly Weinreb, Orit Bar-Am, Ksenia Prosolovich, et al.
Molecular Neurobiology
|
August 1, 2012
Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in mice
Lana Kupershmidt, Tamar Amit, Orit Bar-Am, et al.
Journal of Neurochemistry
|
August 8, 2007
The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases
Lana Kupershmidt, Tamar Amit, Orit Bar-Am, et al.
Page
of 7